Dan Primack
&
Albert Bourla
,
Axios Re:Cap
Pfizer CEO Albert Bourla on the blockbuster COVID-19 vaccine news
09 Nov 2020
• 14 min
• EN
Pfizer on Monday announced that its COVID-19 vaccine has proven effective in preventing infection in over 90% of Phase 3 clinical trial patients, and added that it could have 50 million doses available by year-end. Dan talks to Pfizer CEO Albert Bourla about data, distribution, politics, and how he reacted upon receiving the news. Learn more about your ad choices. Visit megaphone.fm/adchoices
From "Axios Re:Cap"
Comments
Add comment Feedback